See also this year's filing and all EDGAR filings for this company.
PDF Report 0001811623_2023_Kuvatris_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001811623, Kuvatris Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,204,318 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,095,518 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,816,940 |
| 9 | ResearchAndDevelopmentExpense | 1,787,488 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -4,197,339 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,204,318 |
| 1 | Liabilities | 2,095,518 |
| 2 | Expenses | 10,604,428 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 108,800 |
| 5 | NetIncome | -14,801,767 |
| 6 | ComprehensiveNetIncome | -14,801,767 |
| 7 | BaseVar | 9,550,802 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -6.77 |
| 9 | EconomicCapitalRatio | 0.0359 |
Edgar->Model Mapping
Feature Distribution
